key: cord-0737439-9ngy4ddm authors: Baildya, Nabajyoti; Ghosh, Narendra Nath; Chattopadhyay, Asoke P.; Mandal, Vivekananda; Majumdar, Sourav; Ansary, Delwar; Sarkar, Md Muttakin title: Inhibitory effect of compounds extracted from Monochoria hastata (L.) Solms on SARS-CoV-2 main protease: An insight from molecular docking and MD-simulation studies date: 2022-02-15 journal: J Mol Struct DOI: 10.1016/j.molstruc.2022.132644 sha: 32a4f94e4e946f0a42251c181006e234f4c8d580 doc_id: 737439 cord_uid: 9ngy4ddm Using molecular docking and other studies, 20 compounds extracted from Monochoria hastata (L.) Solms were screened, and their inhibitory efficiency examined against main protease (3CLpro) of SARS CoV-2. All the compounds were found to binding with 3CLpro through van der Waals and electrostatic forces of attractions. Among them, Azelaic dihydrazide (ADZ) was found to have the highest docking score. 3CLpro-ADZ complex was studied by MD simulation. ADZ was found to disrupt the structure of 3CLpro after 2 ns. RMSD and RMSF analysis along with sequence and binding energy analysis suggest that ADZ can be a potential drug against SARS CoV-2. The devastating effect of novel coronavirus disease, COVID-19, progressively affects global health and economy. Such an emergency throws a challenge to the entire scientific community to work together and come up with an effective antidote against this deadly virus (SARS-CoV-2). Numerous attempts have been made to find useful drugs or vaccines to combat this virus [1] [2] [3] [4] . But till date, no specific drug has been found. Drugs like chloroquine, hydroxychloroquine, favipiravir, remdesivir, azithromycine etc. [5] [6] [7] [8] [9] , extracts from different plants [10] [11] [12] , normally used in other diseases, are under clinical trial against this virus, but they are being used with caution. Coronavirus was first found in 1960 [13] . It returned in new avatars in 2002 and 2012 to haunt us [14] [15] [16] [17] . However, the novel coronavirus viz. SARS-CoV-2 or COVID-19 has created a pandemic because of its higher transmission rate (R0) compared to previous cases. The SARS-CoV-2 belongs to the -coronavirus group, and its genome is quite similar to that of previous SARS-CoV. Although exact origin of this virus is not clear [18] , it is transmitted rapidly among human beings by community transmission [19] . The outer surface of this virus contains spike glycoprotein, an enveloped membrane and nucleocapsid protein containing a positive sense single strand of RNA. It mainly binds with human angiotensin-converting enzyme-2 (ACE-2) receptors using its spike glycoprotein. Along with spike proteins it contains the cellular serine protease TMPRSS2, cysteine protease, main protease (3CLpro), papain-like protease (PLpro) and different non-structural proteins (nsp) which are basically used for its replication. Therefore, drugs that effectively block one or more of these proteins or the ACE-2 enzyme involved in binding to host cell or those active in replication process are much focused [20] [21] [22] . From ancient times, herbs have been used as effective medicinal resource. There are approximately 25000 plants in India which are used in traditional and folk medicine [23] . An aquatic medicinal plant of India, Monochoria hastata (L.) Solms, belonging to the family Pontederiaceae, is being used as remedy in Indian villages for various disorders. The extracts obtained from its leaf show antibacterial and anti-viral effects. It contains different types of alkaloids, phenols, terpenoids, flavonoids, glycosides, monoacyl glycerol etc. [24] . 20 different compounds were selected from extracts of this plant for in-silico screening against 3CLpro of SARS-CoV-2 by docking and molecular dynamics simulation. The crystal structure of 3CLpro of SARS-COV-2 (PDB ID: 6LU7) was obtained from the Protein Data Bank. The sdf files of the drugs were downloaded from PubChem (National Library of Medicine) and were converted to pdb format to check ligand-protein binding interactions. UCSF Chimera [25] package was used to clean the structure of 3CLpro. Autodock Vina [26] was used to investigate docking between 3CLpro and the drug molecules and necessary files were prepared by using Autodock Tools. Azelaic dihydrazide (ADZ) was found to have the highest docking score with 3CLpro. The minimum energy docked configuration of 3CLpro-ADZ complex was selected for molecular dynamics (MD) simulation studies. GROMACS (version 5.1) [27] was used to perform the MD simulation using CHARMM36-mar2019 force-field [28] with TIP3P solvation model [29] . Ligand parameters and topology files were generated with the help of CHARMM General Force Field server. Periodic boundary conditions were applied to maintain a cubical box in which the 3CLpro-ADZ complex was at least 1 nm from the edges for successive imaging of the complex. To maintain electroneutrality, four Na + ions were added to the system. Energy minimization was carried out by the steepest descent algorithm followed by conjugate gradient protocol, until the system reached a minimum force of 10 kJmol -1 nm -1 . For equilibration of the system, isochoric-isothermal (NVT) ensemble was used at 300K for 100 ps. The time step was set to 2 fs. This was followed by equilibration in an isothermalisobaric (NPT) ensemble for 100 ps at 300K. Modified Berendsen thermostat was used for the NPT ensemble. Here also the time step was set to 2 fs. For both the NVT and NPT equilibration, 1 nm cut-off was kept for van der Waals and electrostatic interactions. For the calculation of long range interactions, smooth particle mesh Ewald (PME) [30] method was used. Finally, MD simulation was performed for 10 ns using the equilibrated ensembles with the same cut off as used before. A modified Berendsen thermostat and a Parinello-Rahman barostat at 300K temperature and 1 bar pressure were used. Snapshots of the trajectory were taken after each nanosecond of simulation. The trjconv tool was used for analysis of structural trajectories of the 3CLpro-ADZ complex during simulation. Drug, water, counter ions and 3CLpro were re-centred within the cubical box using the same tool. Variation of root mean square deviation (RMSD), root mean square fluctuations (RMSF), radius of gyration (Rg) and solvent accessible surface area (SASA) were plotted using xmgrace plotting tool. g_mmpbsa tool [31, 32] was used to calculate average binding free energy, polar free energy (ΔGpolar), non-polar free energy (ΔGnon-polar), average MM-energy (ΔEMM), van der Waals energy, SASA energy and electrostatic energy. The change of binding energy with time was plotted using Origin 8.0. 20 compounds, extracted from Monochoria hastata (L.) Solms, were screened against SARS-CoV-2 main protease (3CLpro). Binding affinity of these compounds was found to be in the range of -3.6 to -5.8 Kcal/mol as shown in Fig. 1 . The highest binding affinity of -5.8 Kcal/mol was observed for Azelaic dihydrazide (ADZ) against 3CLpro. Previous studies showed that Azelaic Acid and its hydrazide derivation have high binding affinity with DNA Polymeraze I (2KFN) due to enhance H-bonding showing its potential inhibitory activity against 2KFN [33] . This observation is in accordance with our simulated results. It has been also reported that Azalaic Acid showed potential anti-viral inhibitory activity [34] . To analyse the stereochemistry of the drug-protein complex we have plotted contour diagram of drug with neighbouring residue of the 3CLpro as shown in Table S2 . van der Waal donoracceptor iso-surfaces of drug-protein complex clearly indicates electrostatic interaction is exists between them while the 2D contour plot demonstrates van der Waal and the number of H-bonding interaction between drug and protein. To predict toxicity of these compounds, ADME toxicity analysis was performed using pkCSM online server [35] . All the estimated pharmacokinetic properties are listed in Table 1 . Pharmacokinetic analysis reveals that the compounds have low blood-brain barrier (BBB) permeability, with values ranging between -0.016 and 0.816. The drugs were found to have no effect on CYP2C9, CYP2D6 and CYP3A4 inhibitors. Skin permeability values were found between -1.384 and -4.376 for the drugs. These drugs also do not inhibit renal OCT2 substrate as shown Table S3 (in Supporting Information). The structural changes of ADZ docked 3CLpro is also corroborated by the sequence analysis of the docked and undocked 3CLpro as shown in Fig. 5 . Sequence analysis revealed that the residues after 202 had completely changed their positions indicating huge conformational change within the 3CLpro. The binding free energy of polar and non-polar groups of the docked structure with respect to time are shown in Fig. 6c and 6d respectively. With the passage of time, polar binding free energy (H-bonding and electrostatic) decreased indicating much stronger binding of the drug ADZ in the 3CLpro cavity. It is to be noted that the stronger binding of ADZ with 3CLpro explains the huge structural change and protein chain sequence changes in 3CLpro. Magnitudes of some major interactions in the 3CLpro-ADZ complex are listed in Table 2 . The compactness of a system is measured by the radius of gyration (Rg) analysis. Variation of Rg with time is shown in Fig. 7a for undocked and docked 3CLpro with ADZ. Form Fig. 7a it is clear that the docked structure is more compact as compared to the undocked one. The solvent accessible surface area (SASA) of docked and undocked 3CLpro are plotted against time in Fig. 7b . The figure clearly shows that the docked structure has lesser surface area compared to the undocked structure, which reveals destabilization of the former. Fig. 8 represents structural changes during MD simulation. From the above analysis it is clear that ADZ creates a large impact to destabilize the structure of 3CLpro. This is also clearly reflected in Fig. 8 . Snapshots are given in the figure after every 2 ns starting from the beginning. The RMSD plot and Fig. 8 are in agreement with each other. At 2 ns, a substential conformational change is indicated in Fig. 4a and in Fig. 8 . The structure continues to change as reflected in Fig. 4a and 4b, and also in Fig. 8 . The docked structure does not seem to attain equilibrium up to 10 ns, i.e. till the end of simulation, whereas the undocked structure of the protease reaches equilibrium after 3 ns, as revealed from the RMSD plot (Fig. 4a) . It is clear, therefore, that the molecule ADZ from M. hastata destabilized the structure of 3CLpro on binding with it. This is expected to affect the activity of SARS-CoV-2 to noticeable extent. 3CLpro plays an essential role in processing the ploy proteins translated from viral RNA and thus aids in replication of the coronavirus. Inactivation of 3CLpro is therefore expected to lead to inhibiting viral replication of SARS-CoV-2. 20 compounds from the extract of the ethnomedical aquatic herb M. hastata (L) Solms were screened against the main protease (3CLpro) of the novel coronavirus SARS-CoV-2. All the compounds were found to have good docking affinity with 3CLpro, as also desirable properties of pharmacokinetics, as obtained from ADME and related analysis. Among all the compounds, Azelaic dihydrazide (ADZ) was found to have the best docking score with 3CLpro. This docked structure of 3CLpro-ADZ was then subject to molecular dynamics (MD) simulation for 10 ns. Analysis of the simulation data viz. RMSD, RMSF, Rg and SASA plots, as well as from the structures of the 3CLpro-ADZ complex during simulation, the following conclusion can be drawn: ADZ creates a large conformational change on The authors declare no conflicting interest in the present work. Chloroquine and hydroxychloroquine as available weapons to fight COVID-19 Chloroquine for the 2019 novel coronavirus SARS-CoV-2 Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies Novel Coronavirus Disease (COVID-19): An extensive study on evolution, global health, drug targets and vaccines Inhibitory activity of hydroxychloroquine on COVID-19 main protease: An insight from MD-simulation studies Inhibitory capacity of chloroquine against SARS-COV-2 by effective binding with angiotensin converting enzyme-2 receptor: An insight from molecular docking and MD-simulation studies Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study Inhibitory efficiency of potential drugs against SARS-CoV-2 by blocking human angiotensin converting enzyme-2: Virtual screening and molecular dynamics study Inhibitory efficacy of RNA virus drugs against SARS-CoV-2 proteins: An extensive study Screening of potential drug from Azadirachta Indica (Neem) extracts for SARS-CoV-2: An insight from molecular docking and MD-simulation studies Screening of potential anti-HIV compounds from Achyranthes aspera extracts for SARS-CoV-2: An insight from molecular docking study Inhibitory effect of anti-HIV compounds extracted from Indian medicinal plants to retard the replication and transcription process of SARS-CoV-2: an insight from molecular docking and MD-simulation studies Cultivation of viruses from a high proportion of patients with colds Identification of a novel coronavirus in patients with severe acute respiratory syndrome History and recent advances in coronavirus discovery A novel coronavirus associated with severe acute respiratory syndrome Coronavirus as a possible cause of severe acute respiratory syndrome SARS-CoV-2: an emerging coronavirus that causes a global threat of the International, The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 Mechanisms of coronavirus cell entry mediated by the viral spike protein Emergence of MERS-CoV in the Middle East: origins, transmission, treatment, and perspectives The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds Indian traditional ayurvedic system of medicine and nutritional supplementation In-vitro antioxidant and antibacterial activity and phytochemical profile of methanol extract of Monochoria hastata (L.) Solms leaf UCSF Chimera-a visualization system for exploratory research and analysis AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading GROMACS: a message-passing parallel molecular dynamics implementation CHARMM36 united atom chain model for lipids and surfactants CHARMM TIP3P water model suppresses peptide folding by solvating the unfolded state Optimization of parameters for molecular dynamics simulation using smooth particle-mesh Ewald in GROMACS 4 Electrostatics of nanosystems: application to microtubules and the ribosome g_mmpbsa A GROMACS tool for high-throughput MM-PBSA calculations Molecular recognition of azelaic acid and related molecules with DNA polymerase I investigated by molecular modeling calculations Azelaic acid: pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures The authors wish to acknowledge infrastructural support from Department of Chemistry, University of Kalyani, Kalyani, Nadia, India. The authors also like to acknowledge Dr.